review of glp 1 drops If you or your patient is starting a GLP-1 receptor agonist with type diabetes, here is what the clinical trial evidence says should happen. Insulin fast — at the starting Does Insurance Cover Weight Loss

If you need further assistance, feel free to reach out

GLP-1s could help patients achieve lower BMI

The oral wave could change the math, but its not a lock

People experiencing severe side effects are prescribed lower dosages

A study of 30 patients with type 2 diabetes treated for 8 weeks showed measurable reductions in CD62p (a marker of platelet activation) and PAC-1 (a marker of glycoprotein IIb/IIIa complex activation, the final common pathway of platelet aggregation)

GLP1-based treatments reduce the production of various inflammatory cytokines and infiltration of immune cells in the liver, kidney, lung, brain and the cardiovascular system 63,91,94